Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Figure 4

Changes of fasting glycemia with treatment in the whole group and separately for F0-F2, F3, and F4 (Metavir) fibrosis patients. EoT: end of treatment; EoT+12w: 12 weeks after the end of treatment.